Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes

Currently available medications for the treatment of type 2 diabetes have limitations, and many patients do not achieve glycaemic control. Recently, a new approach has emerged using sodium glucose co-transporter 2 (SGLT2) inhibitors that decrease glucose reabsorption in the kidneys, increasing urina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Endocrinol
Main Authors: A Oliveros, Rene, V Pham, Son, R Bailey, Steven, J Chilton, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: Touch Medical Media 2014
Assuntos:
Diabetes Management
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983080/
https://ncbi.nlm.nih.gov/pubmed/29872475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2014.10.02.117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados